Philips, Immunetrics Unite to Target Infectious Disease | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Philips, Immunetrics Unite to Target Infectious Disease

February 4, 2009
by root
| Reprints

Royal Philips Electronics (Netherlands) and

Immunetrics Inc. (Pittsburgh) are teaming up to explore future-generation approaches to improve the treatment of infectious disease in critical care.

Under the joint development agreement, Philips Research and Immunetrics will investigate the combination of advanced bioinformatics and computer modeling to identify opportunities to reduce the incidence and improve the management of systemic infection, a major complicating factor among many critically ill patients, say the companies.

Philips currently owns a 29 percent stake in Immunetrics, a biosimulation company specializing in the computational modeling of pathophysiology and treatment.

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


See more on

betebet sohbet hattı betebet bahis siteleringsbahis